Clinical Trials · NCT02488512
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Enrollment
- 1
- Start date
- Dec 2016
- Locations
- 1 site, Italy
- Primary endpoint
- overall response rate (ORR)